Cyclobenzaprine
Overview
Cyclobenzaprine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL669).
API suppliers (8)
Suppliers of Cyclobenzaprine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
7 of 8 hold a GMP certificate on record in the EU or UK registers
- VASUDHA PHARMA CHEM LTDIndia1 active DMF
- Unichem Laboratories Ltd.India1 active DMF GMP on record
- MEDICHEM SASpain1 active DMF GMP on record
- Dipharma Francis SrlItaly1 active DMF GMP on record
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- FLEMING LABORATORIES LTDIndia GMP on record
- FERMION OYFinland GMP on record
- CILAG AGSwitzerland GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (40 approved US products), the latest listed US patent on Cyclobenzaprine expires 14 Mar 2034 and exclusivity 15 Aug 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine
- Canonical SMILES
- CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
- InChIKey
- JURKNVYFZMSNLP-UHFFFAOYSA-N
Do you supply Cyclobenzaprine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.